Effect of Bojungikki-tang on Lipopolysaccharide-Induced Cytokine Production from Peripheral Blood Mononuclear Cells of Chronic Fatigue Syndrome Patients

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 4, 2003, Pages 491-501

  Shin, Hye Young ^a,b   Shin, Chang Ho ^c   Shin, Tae Yong ^d   Lee, Eon Jeong ^b   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c SKY Sports Medicine Lab   (South Korea)

^d Woosuk University   (South Korea)

Author keywords

Bojungikki tang; Chronic fatigue syndrome; Cytokines; Lipopolysaccharide

Indexed keywords

BOJUNGIKKI TANG; CYTOKINE; GAMMA INTERFERON; HERBACEOUS AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CYTOKINE PRODUCTION; HUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; CYTOKINES; FATIGUE SYNDROME, CHRONIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344304617     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120026435     Document Type: Article

References (57)

1. Visser, J.; Blauw, B.; Hinloopen, B.; Brommer, E.; de Kloet, E.R.; Kluft, C.; Nagelkerken, L. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J. Infect. Dis. 1998, 2, 451.
2. Cannon, J.G.; Angel, J.B.; Abad, L.W.; Vannier, E.; Mileno, M.D.; Fagioli, L.; Wolff, S.M.; Komaroff, A.L. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J. Clin. Immunol. 1997, 3, 253.
3. Bennett, A.L.; Chao, C.C.; Hu, S.; Buchwald, D.; Fagioli, L.R.; Schur, P.H.; Peterson, P.K.; Komaroff, A.L. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J. Clin. Immunol. 1997, 2, 160.
4. Buchwald, D.; Wener, M.H.; Pearlman, T.; Kith, P. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J. Rheumatol. 1997, 2, 372.
5. Levy, J.A. Viral studies of chronic fatigue syndrome. Clin. Infect. Dis. 1994, 18, S117.
6. Bearn, J.; Wessely, S. Neurobiological aspects of the chronic fatigue syndrome. Eur. J. Clin. Invest. 1994, 2, 79.
7. Strauss, S.E.; Komaroff, A.L.; Wedner, H.J. Chronic fatigue syndrome. Point and counterpoint. J. Infect. Dis. 1994, 170, 1.
8. Aoki, T.; Miyakoshi, H.; Usuda, Y.; Herberman, R.B. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin. Immunol. Immunopathol. 1993, 3, 253.
9. Caligiuri, M.; Murray, C.; Buchwald, D.; Levine, H.; Cheney, P.; Peterson, D.; Komaroff, A.L.; Ritz, J. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 1987, 139, 3306.
10. Barker, E.; Fujimura, S.E; Fadem, M.B.; Landay, A.L.; Levy, J.A. Immunologic abnormalities associated with chronic fatigue syndrome. Clin. Infect. Dis. Suppl. 1994, 1, S136.
11. Strauss, S.E.; Fritz, S.; Dale, J.K.; Gould, B.; Strober, W. Lymfocyte phenotype and function in the chronic fatigue syndrome. J. Clin. Immunol. 1993, 13, 30.
12. Swanink, C.M.; Vercoulen, J.H.; Bleijenberg, G.; Fennis, J.F.; Galama, J.M.; van der Meer, J.W. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J. Intern. Med. 1995, 237, 499.
13. Klimas, N.G.; Salvato, F.R.; Morgan, R.; Fletcher, M.A. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 1990, 28, 1403.
14. Chao, C.C.; Janoff, E.N.; Hu, S.X.; Thomas, K.; Gallagher, M.; Tsang, M. ; Peterson, P.K. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991, 3, 292.
15. Swanink, C.M.; Vercoulen, J.H.; Galama, J.M.; Roos, M.T.; Meyaard, L.; van der Ven-Jongekrijg, J.; de Nijs, R.; Bleijenberg, G.; Fennis, J.F.; Miedema, F.; van der Meer, J.W. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J. Infect. Dis. 1996, 173, 460.
16. Mawle, A.C.; Nisenbaum, R.; Dobbins, J.G.; Gary, H.E., Jr.; Stewart, J.A.; Reyes, M.; Steele, L.; Schmid, D.S.; Reeves, W.C. Immune responses associated with chronic fatigue syndrome: a case-control study. J. Infect. Dis. 1997, 175, 136.
17. Hassan, I.S.; Bannister, B.A.; Akbar, A.; Weir, W.; Bofill, M. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin. Immunol. Immunopathol. 1998, 87, 60.
18. Tirelli, U.; Marotta, G.; Improta, S.; Pinto, A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand. J. Immunol. 1994, 40, 601.
19. Landay, A.L.; Jessop, C.; Lennette, E.T.; Levy, J.A. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991, 338, 707.
20. Moutschen, M.; Triffaux, J.M.; Demonty, J.; Legros, J.J.; Lefebvre, P.J. Pathogenic tracks in fatigue syndromes. Acta. Clin. Belg. 1994, 49, 274.
21. Buchwald, D.; Komaroff, A.L. Review of laboratory findings for patients with chronic fatigue syndrome. Rev. Infect. Dis. 1991, 13, S12.
22. Gupta, S.; Vayuvegula, B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand. J. Immunol. 1991, 33, 319.
23. Gupta, S. Recent developments in immunological aspects of chronic fatigue syndrome. In The Clinical and Scientific Basis of Myalgic Encephalomyelitis Chronic Fatigue Syndrome; The Nightingale Research Foundation: New York, 1992; 545 pp.
24. Jone, J.F. Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus. Rev. Infect. Dis. 1991, 1, S26.
25. Lloyed, A.R.; Wakefield, D.; Dwyer, J.; Boughton, C. Immunological abnormalities in chronic fatigue syndrome. Med. J. Aust. 1989, 151, 122.
26. Straus, S.E.; Dale, J.K.; Peter, J.B.; Dinnarello, C.A. Circulating lymphokine levels in the chronic fatigue syndrome. J. Infect. Dis. 1989, 160, 1085.
27. Krakauer, T.; Vilcek, J.; Oppenheim, J.J. Proinflammatory cytokines: TNF and IL-1 families, chemokines, TGF-β, and others. In Fundamental Immunology, 4th Ed.; Paul, W.E., Ed.; Lippincott-Raven: New York, 1999; 775 pp.
28. Vgontzas, A.N.; Papanicolaou, D.A.; Bixler, E.O.; Kales, A.; Tyson, K.; Chrousos, G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrino. Metab. 1997, 82, 1313.
29. Papanicolaou, D.A.; Wilder, R.L.; Manolagas, S.C.; Chrousos, G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998, 128, 127.
30. Dusheiko, G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997, 26, 112S.
31. Howard, M.; O'Garra, A.; Ishida, H.; de Waal Malefyt, R.; de Vries, J. Biological properties of interleukin 10. J. Clin. Immunol. 1992, 12, 239.
32. Fiorentino, D.F.; Zlotnik, A.; Mosmann, T.R.; Howard, M.; O'Garra, A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147, 3815.
33. Lopez, A.R.; Cook, J.; Deininger, P.L.; Derynck, R. Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms. Mol. Cell. Biol. 1992, 12, 1674.
34. Aung, H.; Toossi, Z.; McKenna, S.M.; Gogate, P.; Sierra, J.; Sada, E.; Rich, E.A. Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma, and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber. Lung. Dis. 2000, 80, 61.
35. Hirsch, C.S.; Yoneda, T.; Averill, L.; Ellner, J.J.; Toossi, Z. Enhancement of intracellular growth of mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J. Infect. Dis. 1994, 170, 1229.
36. Gorelik, L.; Flavell, R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12, 171.
37. Fukuda, K.; Straus, S.E.; Hickie, I.; Sharpe, M.C.; Dobbins, J.G.; Komaroff, A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994, 121, 953.
38. Scuderi, P.; Sterling, K.E.; Lam, K.S.; Finley, P.R.; Ryan, K.J.; Ray, C.G.; Petersen, E.; Slymen, D.J.; Salmon, S.E. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 1986, 2, 1364.
39. Matsuyama, T.; Kobayashi, N.; Yamamoto, N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991, 5, 1405.
40. Brosnan, C.F.; Selmaj, K.; Raine, CS. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 1988, 18, 87.
41. Shoham, S.; Davenne, D.; Cady, A.B.; Dinarello, C.A.; Krueger, J.M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am. J. Physiol. 1987, 253, R142.
42. Gordon, M.S.; Nemunaitis, J.; Hoffman, R.; Paquette, R.L.; Rosenfeld, C. ; Manfreda, S.; Isaacs, R.; Nimer, S.D. A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood 1995, 85, 3066.
43. Arvidson, N.G.; Gudbjornsson, B.; Elfman, L.; Ryden, A.C.; Totterman, T.H.; Hallgren, R. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann. Rheum. Dis. 1994, 53, 521.
44. Davas, E.M.; Tsirogianni, A.; Kappou, I.; Karamitsos, D.; Economidou, I. ; Dantis, P.C. Serum IL-6, TNF alpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin. Rheumatol. 1999, 18, 17.
45. Rovaris, M.; Barnes, D.; Woodrofe, N.; du Boulay, G.H.; Thorp, J.W.; Thompson, A.J.; McDonald, W.I.; Miller, D.H. Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J. Neurol. 1996, 243, 536.
46. Tilg, H.; Wilmer, A.; Vogel, W.; Herold, M.; Nolchen, B.; Judmaier, G.; Huber, C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992, 103, 264.
47. Plevris, J.N.; Blair, C.; Cossar, J.A.; Dollinger, M.M.; O'Carroll, R.E. ; Hayes, P.C. Chronic fatigue is associated with increased interlukin-6 in patients with chronic liver disease. Hepatology 1997, 26, A1818.
48. Gupta, S.; Aggarwal, S.; See, D.; Starr, A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J. Psychiatr. Res. 1997, 31, 149.
49. van Boxel-Dezaire, A.H.; Hoff, S.C.; van Oosten, B.W.; Verweij, C.L.; Drager, A.M.; Ader, H.J.; van Houwelingen, J.C.; Barkhof, F.; Polman, C.H.; Nagelkerken, L. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 1999, 45, 695.
50. Visser, J.; Graffelman, W.; Blauw, B.; Haspels, I.; Lentjes, E.; de Kloet, E.R.; Nagelkerken, L. LPS-induced IL-10 production in whole blood cultures from chronic fatigue syndrome patients is increased but supersensitive to inhibition by dexamethasone. J. Neuroimmunol. 2001, 119, 343.
51. Border, W.A.; Ruoslahti, E. Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 1992, 90, 1.
52. Koyanagi, M.; Egashira, K.; Kubo-Inoue, M.; Usui, M.; Kitamoto, S.; Tomita, H.; Shimokawa, H.; Takeshita, A. Role of transforming growth factor-betal in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. Hypertension 2000, 35, 86.
53. Barral, A.; Barral-Netto, M.; Yong, E.C.; Brownell, C.E.; Twardzik, D.R. ; Reed, S.G. Transforming growth factor beta as a virulence mechanism for leishmania braziliensis. Proc. Natl. Acad. Sci. USA 1993, 90, 3442.
54. Reed, S.G. TGF-beta in infections and infectious diseases. Microb. Infect. 1999, 1, 1313.
55. Andersson, P.O.; Olsson, A.; Wadenvik, H. Reduced transforming growth factor-betal production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. 2002, 116, 862.
56. Targan, S., Stebbing, N. In vitro interactions of purified cloned human interferons on NK cells: enhanced activation. J. Immunol. 1982, 129, 934.
57. Knop, J.; Stremer, R.; Nauman, C.; deMaeyer, E.; Macher, M. Interferon inhibits the suppressor T cell response of delayed hypersensitivity. Nature 1982, 296, 757.